查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2155688

新生兒遺傳疾病診斷市場：全球市場預測，2026-2032年

Neonatal Genetic Disease Diagnosis Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，新生兒遺傳疾病診斷市場將成長至 46 億美元，複合年成長率為 8.98%。

主要市場統計數據
基準年 2025 25.2億美元
預計年份：2026年 27.1億美元
預測年份 2032 46億美元
複合年成長率 (%) 8.98%

新生兒遺傳疾病的診斷：概述

新生兒遺傳疾病的診斷包括篩檢、確診檢測和臨床解讀，旨在出生後立即識別遺傳疾病。隨著基因組技術、生化檢測和多學科診療模式的進步，在症狀發展到不可逆轉之前發現疾病的能力不斷提高，新生兒遺傳疾病的診斷也日益重要。有效的項目會將經過檢驗的檢測方法與家長諮詢、確診評估、轉診途徑以及早期治療相結合。

篩檢正朝著更早期、更全面的照護方向發展。

該領域正從單一疾病的獨立檢測轉向整合新生兒篩檢、快速分子檢測、臨床評估和長期後續觀察的協作式診斷流程。次世代定序的普及擴大了可檢測突變的範圍，而檢查室自動化和數據解讀技術的進步則實現了快速出具檢測結果。然而，關鍵的實施挑戰仍然存在，包括突變解讀、假陽性結果管理、知情同意、公平獲取以及如何將檢測結果與專業臨床服務相結合。

人工智慧正在提升解讀能力和工作流程。

人工智慧透過突變優先排序、表現型匹配、影像和波形分析、品管以及工作流程篩選，為新生兒遺傳疾病的診斷做出貢獻。其最大的實際價值在於累積：它可以幫助檢查室管理複雜的資料集，協助臨床醫生識別模式，並透過與檢驗的方案整合來減輕人工審核的負擔。然而，由於新生兒症狀通常特異性，訓練資料在不同人群中可能存在異質性，且演算法輸出需要臨床驗證和適當的管治，因此人工監督仍然至關重要。

區域差異反映了醫療衛生系統的能力和政策。

北美地區擁有完善的新生兒篩檢基礎設施、先進的基因組學服務，對嚴重嬰兒快速檢測的需求日益成長。歐洲受益於強大的公共衛生機構和跨境科學合作，但在篩檢計畫、保險報銷和知情同意要求方面存在差異。在亞太地區，澳洲、日本和韓國等經濟強國的先進能力與全部區域普遍存在的醫療資源取得不均並存。拉丁美洲正在擴大其檢查室和轉診能力，但仍面臨地理和資源的限制。在中東，專業基因組學計畫正與國家醫療衛生系統的現代化進程同步發展。非洲在改善早期診斷方面擁有巨大的潛力，但檢查室基礎設施匱乏、人員短缺以及參考資料集代表性不足仍然是主要障礙。

主要多邊組織可以努力實現標準和准入的統一。

東協合作可以支援跨不同醫療衛生體系的通用檢測標準、轉診網路和人力資源發展。金磚國家可以在考慮各自不同的法規環境的同時，促進在可負擔的定序、本地化生產、數據資源和能力建設方面的合作。歐盟可以加強在互通性、跨境轉診系統和資料管治方面的通用。七國集團成員國可以為循證標準、負責任的人工智慧實踐和全球技術援助做出貢獻。海灣合作理事會成員國可以協調專業服務、篩檢政策和基因組資料管理。北約成員國可以從互通的緊急應變和檢測能力中受益，尤其是在新生兒診斷與緊急計畫和跨境衛生準備相結合的領域。

每個國家的優先事項各不相同，從擴大該計劃到確保公平性。

澳洲可以在發揮其協調篩檢和基因組學專長的同時，改善偏遠社區的醫療服務可近性。巴西和墨西哥有機會加強區域轉診網路、偵測能力以及在地理分散的人群中進行後續工作。加拿大和美國可以繼續將快速基因組檢測納入重症監護流程，並提高基因組資料集的代表性。中國、印度、俄羅斯和韓國有能力擴大國內檢測能力，同時解決人口多樣性、監管一致性以及主要都會區以外地區的醫療服務可近性問題。法國、德國、義大利、西班牙和英國可以進一步加強歐洲內部篩檢政策、保險報銷、資料管治和跨境臨床方案的協調一致。日本可以繼續推進新生兒護理領域的精準診斷、品質保證和專家間的合作。

領導者的首要任務：協調檢測和及時的臨床介入。

產業領導者應設計涵蓋整個診斷流程的服務，而不僅僅是檢測本身。優先事項應包括在代表性人群中檢驗檢測方法、發布透明的效能指標、建立快速確診流程以及將遺傳諮詢整合到醫療保健服務中。各機構需要投資於可互通的檢測和臨床數據系統、制定清晰的人工智慧 (AI)管治，並監測醫療服務取得和治療結果的差異。與醫院、公共衛生機構、病患團體和學術機構的合作將有助於改善實施。此外，人才培育計畫需要解決臨床遺傳學、生物資訊學、遺傳諮詢和新生兒醫學領域的人員短缺問題。

調查方法：基於證據的診斷實踐綜合分析

本執行摘要對新生兒遺傳疾病診斷領域已取得的進展進行了結構化、定性和綜合性的分析，涵蓋篩檢實踐、基因組檢測、檢查室操作、臨床整合、人工智慧應用、政策考慮以及醫療保健系統能力等方面。研究結果按指定區域、國家組和具體國家進行分類。本評估著重於已證實的臨床和操作趨勢，避免未經證實的數位論斷，並區分技術潛力與檢驗的臨床效用。解讀本報告時，應結合最新的國家指南、監管決策、同行評審的證據以及區域實施數據。

結論：早期診斷需要一個綜合且公平的系統。

新生兒遺傳疾病的診斷正朝著更快、更全面、更協調的方向發展。基因組技術和人工智慧可以提高檢測和解讀能力，但其效果取決於確診、諮詢、專家診療、負責任的數據使用以及公平的實施。將技術檢驗與完善的臨床路徑和跨區域合作相結合的領導者，將更有能力將早期診斷轉化為對新生兒及其家庭有意義的成果。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 新生兒遺傳疾病診斷市場：依技術分類

  • 微陣列
    • CGH陣列
    • SNP晶片
  • PCR
    • 數位PCR
    • qPCR
  • 定序
    • NGS
    • 桑格法

第8章 新生兒遺傳疾病診斷市場：依疾病類型分類

  • 染色體異常
  • 代謝紊亂
  • 單基因疾病

第9章 新生兒遺傳疾病診斷市場：依檢測方法分類

  • 侵入性
  • 非侵入性

第10章 新生兒遺傳疾病診斷市場：依樣本類型分類

  • 羊水
  • 血
  • 組織
  • 臍帶血

第11章 新生兒遺傳疾病診斷市場：依最終用戶分類

  • 診斷檢查室
  • 醫院
  • 研究機構

第12章 新生兒遺傳疾病診斷市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 新生兒遺傳疾病診斷市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 新生兒遺傳疾病診斷市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Agilent Technologies, Inc.
  • Baylor Genetics
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Fulgent Genetics, Inc.
  • GeneDx Holdings Corp.
  • Guardant Health, Inc.
  • Illumina, Inc.
  • Invitae Corporation
  • Laboratory Corporation of America Holdings
  • Natera, Inc.
  • Oxford Nanopore Technologies plc
  • Personalis, Inc.
  • Quest Diagnostics Incorporated
  • Sophia Genetics SA
  • The Children's Hospital of Philadelphia
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation

第17章 主要專家

Product Code: MRR-537DB9F47155

The Neonatal Genetic Disease Diagnosis Market is projected to grow by USD 4.60 billion at a CAGR of 8.98% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.52 billion
Estimated Year [2026] USD 2.71 billion
Forecast Year [2032] USD 4.60 billion
CAGR (%) 8.98%

Neonatal Genetic Disease Diagnosis: Executive Overview

Neonatal genetic disease diagnosis encompasses screening, confirmatory testing, and clinical interpretation used to identify inherited conditions shortly after birth. Its importance is increasing as genomic technologies, biochemical assays, and multidisciplinary care pathways improve the ability to detect disorders before symptoms become irreversible. Effective programs combine validated testing with parental counseling, confirmatory evaluation, referral pathways, and access to early treatment.

Screening Is Shifting Toward Earlier, More Integrated Care

The field is moving from isolated condition-specific testing toward coordinated diagnostic pathways that link newborn screening, rapid molecular testing, clinical assessment, and longitudinal follow-up. Wider use of next-generation sequencing is expanding the range of detectable variants, while improvements in laboratory automation and data interpretation are supporting faster turnaround. Key implementation challenges remain, including variant interpretation, false-positive management, informed consent, equitable access, and the need to connect test results with specialized clinical services.

Artificial Intelligence Is Strengthening Interpretation and Workflow

Artificial intelligence is contributing to neonatal genetic disease diagnosis through variant prioritization, phenotype matching, image and waveform analysis, quality control, and workflow triage. Its greatest practical value is cumulative: it can help laboratories manage complex datasets, assist clinicians in recognizing patterns, and reduce manual review burdens when integrated with validated protocols. Human oversight remains essential because neonatal presentations are often nonspecific, training data may be uneven across populations, and algorithmic outputs require clinical confirmation and appropriate governance.

Regional Differences Reflect Health-System Capacity and Policy

North America is characterized by established newborn-screening infrastructure, advanced genomic services, and growing interest in rapid testing for critically ill infants. Europe benefits from strong public-health institutions and cross-border scientific collaboration, although screening panels, reimbursement, and consent requirements vary. Asia-Pacific combines advanced capabilities in economies such as Australia, Japan, and South Korea with substantial access differences across the wider region. Latin America is expanding laboratory and referral capacity but continues to face geographic and resource constraints. The Middle East is developing specialized genomic programs alongside national health-system modernization. Africa has important opportunities to improve early diagnosis, yet limited laboratory infrastructure, workforce shortages, and underrepresentation in reference datasets remain significant barriers.

Major Multilateral Groups Can Align Standards and Access

ASEAN cooperation can support shared laboratory standards, referral networks, and workforce development across diverse health systems. BRICS countries can advance collaboration on affordable sequencing, local manufacturing, data resources, and capacity building while accounting for different regulatory environments. The European Union can strengthen interoperability, cross-border referral, and common approaches to data governance. G7 members can contribute to evidence standards, responsible artificial-intelligence practices, and global technical assistance. GCC states can coordinate specialized services, screening policies, and genomic data stewardship. NATO members may benefit from interoperable emergency and laboratory capabilities, particularly where neonatal diagnosis intersects with resilience planning and cross-border health preparedness.

Country Priorities Range from Program Expansion to Equity

Australia can build on coordinated screening and genomic expertise while improving access across remote communities. Brazil and Mexico face opportunities to strengthen regional referral networks, laboratory capacity, and follow-up in geographically dispersed populations. Canada and the United States can continue integrating rapid genomic testing with critical-care pathways and improve representation in genomic datasets. China, India, Russia, and South Korea are positioned to expand domestic laboratory capabilities while addressing population diversity, regulatory consistency, and access outside major centers. France, Germany, Italy, Spain, and the United Kingdom can further align screening policies, reimbursement, data governance, and cross-border clinical pathways within Europe. Japan can continue advancing precision diagnostics, quality assurance, and specialist coordination for neonatal care.

Priorities for Leaders: Link Testing to Timely Clinical Action

Industry leaders should design services around the full diagnostic pathway rather than the test alone. Priorities include validating assays in representative populations, publishing transparent performance metrics, establishing rapid confirmatory pathways, and embedding genetic counseling into care delivery. Organizations should invest in interoperable laboratory and clinical data systems, develop clear artificial-intelligence governance, and monitor disparities in access and outcomes. Partnerships with hospitals, public-health agencies, patient organizations, and academic centers can improve implementation, while workforce programs should address shortages in laboratory genetics, bioinformatics, counseling, and neonatal specialty care.

Methodology: Evidence-Based Synthesis of Diagnostic Practice

This executive summary uses a structured qualitative synthesis of established developments in neonatal genetic disease diagnosis, including screening practice, genomic testing, laboratory operations, clinical integration, artificial-intelligence applications, policy considerations, and health-system capacity. Insights are organized across the specified regions, country groups, and countries. The assessment emphasizes documented clinical and operational trends, avoids unsupported numerical claims, and distinguishes technology potential from validated clinical utility. Interpretation should be complemented by current national guidelines, regulatory decisions, peer-reviewed evidence, and local implementation data.

Conclusion: Earlier Diagnosis Requires Integrated, Equitable Systems

Neonatal genetic disease diagnosis is progressing toward faster, broader, and more connected care. Genomic technologies and artificial intelligence can improve detection and interpretation, but their impact depends on confirmation, counseling, specialist access, responsible data use, and equitable implementation. Leaders that combine technical validation with robust clinical pathways and regional collaboration will be better positioned to translate earlier diagnosis into meaningful outcomes for newborns and families.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Neonatal Genetic Disease Diagnosis Market, by Technology

  • 7.1. Introduction
  • 7.2. Microarrays
    • 7.2.1. Cgh Array
    • 7.2.2. Snp Array
  • 7.3. Pcr
    • 7.3.1. Digital Pcr
    • 7.3.2. Qpcr
  • 7.4. Sequencing
    • 7.4.1. Ngs
    • 7.4.2. Sanger

8. Neonatal Genetic Disease Diagnosis Market, by Disease Type

  • 8.1. Introduction
  • 8.2. Chromosomal Abnormality
  • 8.3. Metabolic Disorder
  • 8.4. Single Gene Disorder

9. Neonatal Genetic Disease Diagnosis Market, by Testing Mode

  • 9.1. Introduction
  • 9.2. Invasive
  • 9.3. Non Invasive

10. Neonatal Genetic Disease Diagnosis Market, by Sample Type

  • 10.1. Introduction
  • 10.2. Amniotic Fluid
  • 10.3. Blood
  • 10.4. Tissue
  • 10.5. Umbilical Cord Blood

11. Neonatal Genetic Disease Diagnosis Market, by End User

  • 11.1. Introduction
  • 11.2. Diagnostic Laboratories
  • 11.3. Hospitals
  • 11.4. Research Institutes

12. Neonatal Genetic Disease Diagnosis Market, by Region

  • 12.1. Introduction
  • 12.2. Asia-Pacific
  • 12.3. North America
  • 12.4. Latin America
  • 12.5. Europe
  • 12.6. Middle East
  • 12.7. Africa

13. Neonatal Genetic Disease Diagnosis Market, by Group

  • 13.1. Introduction
  • 13.2. ASEAN
  • 13.3. GCC
  • 13.4. European Union
  • 13.5. BRICS
  • 13.6. G7
  • 13.7. NATO

14. Neonatal Genetic Disease Diagnosis Market, by Country

  • 14.1. Introduction
  • 14.2. United States
  • 14.3. Canada
  • 14.4. Mexico
  • 14.5. Brazil
  • 14.6. United Kingdom
  • 14.7. Germany
  • 14.8. France
  • 14.9. Russia
  • 14.10. Italy
  • 14.11. Spain
  • 14.12. China
  • 14.13. India
  • 14.14. Japan
  • 14.15. Australia
  • 14.16. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. Market Concentration Analysis, 2025
    • 15.2.1. Concentration Ratio (CR)
    • 15.2.2. Herfindahl Hirschman Index (HHI)
  • 15.3. Recent Developments & Impact Analysis, 2025
  • 15.4. Product Portfolio Analysis, 2025
  • 15.5. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Agilent Technologies, Inc.
  • 16.2. Baylor Genetics
  • 16.3. BGI Genomics Co., Ltd.
  • 16.4. Bio-Rad Laboratories, Inc.
  • 16.5. Danaher Corporation
  • 16.6. F. Hoffmann-La Roche Ltd.
  • 16.7. Fulgent Genetics, Inc.
  • 16.8. GeneDx Holdings Corp.
  • 16.9. Guardant Health, Inc.
  • 16.10. Illumina, Inc.
  • 16.11. Invitae Corporation
  • 16.12. Laboratory Corporation of America Holdings
  • 16.13. Natera, Inc.
  • 16.14. Oxford Nanopore Technologies plc
  • 16.15. Personalis, Inc.
  • 16.16. Quest Diagnostics Incorporated
  • 16.17. Sophia Genetics SA
  • 16.18. The Children's Hospital of Philadelphia
  • 16.19. Thermo Fisher Scientific Inc.
  • 16.20. Twist Bioscience Corporation

17. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Neonatal Genetic Disease Diagnosis Market, Years Considered for the Study
  • FIGURE 2. Global Neonatal Genetic Disease Diagnosis Market, Research Design
  • FIGURE 3. Global Neonatal Genetic Disease Diagnosis Market, Research Framework
  • FIGURE 4. Global Neonatal Genetic Disease Diagnosis Market, Data Triangulation
  • FIGURE 5. Global Neonatal Genetic Disease Diagnosis Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2025 vs 2032 (%)
  • FIGURE 7. Global Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2025 vs 2032 (%)
  • FIGURE 9. Global Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2025 vs 2032 (%)
  • FIGURE 11. Global Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2025 vs 2032 (%)
  • FIGURE 13. Global Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Neonatal Genetic Disease Diagnosis Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 15. Global Neonatal Genetic Disease Diagnosis Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Neonatal Genetic Disease Diagnosis Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 17. Global Neonatal Genetic Disease Diagnosis Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global Neonatal Genetic Disease Diagnosis Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Neonatal Genetic Disease Diagnosis Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 20. Global Neonatal Genetic Disease Diagnosis Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 21. Global Neonatal Genetic Disease Diagnosis Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Neonatal Genetic Disease Diagnosis Market Segmentation & Coverage
  • TABLE 2. Global Neonatal Genetic Disease Diagnosis Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 4. Global Microarrays Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Microarrays Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Microarrays Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Cgh Array Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Cgh Array Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Cgh Array Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Snp Array Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Snp Array Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Snp Array Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Pcr Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Pcr Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Pcr Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Digital Pcr Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 17. Global Digital Pcr Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 18. Global Digital Pcr Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 19. Global Qpcr Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 20. Global Qpcr Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 21. Global Qpcr Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 22. Global Sequencing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 23. Global Sequencing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 24. Global Sequencing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 25. Global Ngs Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 26. Global Ngs Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 27. Global Ngs Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 28. Global Sanger Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 29. Global Sanger Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 30. Global Sanger Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 31. Global Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 32. Global Chromosomal Abnormality Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 33. Global Chromosomal Abnormality Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 34. Global Chromosomal Abnormality Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 35. Global Metabolic Disorder Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 36. Global Metabolic Disorder Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 37. Global Metabolic Disorder Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 38. Global Single Gene Disorder Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 39. Global Single Gene Disorder Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 40. Global Single Gene Disorder Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 41. Global Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
  • TABLE 42. Global Invasive Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 43. Global Invasive Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 44. Global Invasive Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 45. Global Non Invasive Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 46. Global Non Invasive Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 47. Global Non Invasive Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 48. Global Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 49. Global Amniotic Fluid Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 50. Global Amniotic Fluid Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 51. Global Amniotic Fluid Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 52. Global Blood Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 53. Global Blood Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 54. Global Blood Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 55. Global Tissue Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 56. Global Tissue Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 57. Global Tissue Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 58. Global Umbilical Cord Blood Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 59. Global Umbilical Cord Blood Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 60. Global Umbilical Cord Blood Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 61. Global Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 62. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 63. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 64. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 65. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 66. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 67. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 68. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 69. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 70. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 71. Global Neonatal Genetic Disease Diagnosis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 72. Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 73. Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 74. Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
  • TABLE 75. Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
  • TABLE 76. Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
  • TABLE 77. Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 78. Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
  • TABLE 79. Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 80. Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 81. North America Neonatal Genetic Disease Diagnosis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 82. North America Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 83. North America Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
  • TABLE 84. North America Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
  • TABLE 85. North America Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
  • TABLE 86. North America Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 87. North America Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
  • TABLE 88. North America Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 89. North America Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 90. Latin America Neonatal Genetic Disease Diagnosis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 91. Latin America Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 92. Latin America Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
  • TABLE 93. Latin America Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
  • TABLE 94. Latin America Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
  • TABLE 95. Latin America Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 96. Latin America Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
  • TABLE 97. Latin America Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 98. Latin America Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 99. Europe Neonatal Genetic Disease Diagnosis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 100. Europe Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 101. Europe Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
  • TABLE 102. Europe Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
  • TABLE 103. Europe Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
  • TABLE 104. Europe Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 105. Europe Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
  • TABLE 106. Europe Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 107. Europe Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 108. Middle East Neonatal Genetic Disease Diagnosis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 109. Middle East Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 110. Middle East Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
  • TABLE 111. Middle East Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
  • TABLE 112. Middle East Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
  • TABLE 113. Middle East Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 114. Middle East Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
  • TABLE 115. Middle East Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 116. Middle East Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 117. Africa Neonatal Genetic Disease Diagnosis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 118. Africa Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 119. Africa Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
  • TABLE 120. Africa Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
  • TABLE 121. Africa Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
  • TABLE 122. Africa Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 123. Africa Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
  • TABLE 124. Africa Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 125. Africa Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 126. Global Neonatal Genetic Disease Diagnosis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 127. ASEAN Neonatal Genetic Disease Diagnosis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 128. ASEAN Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 129. ASEAN Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
  • TABLE 130. ASEAN Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
  • TABLE 131. ASEAN Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
  • TABLE 132. ASEAN Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 133. ASEAN Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
  • TABLE 134. ASEAN Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 135. ASEAN Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 136. GCC Neonatal Genetic Disease Diagnosis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 137. GCC Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 138. GCC Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
  • TABLE 139. GCC Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
  • TABLE 140. GCC Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
  • TABLE 141. GCC Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 142. GCC Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
  • TABLE 143. GCC Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 144. GCC Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 145. European Union Neonatal Genetic Disease Diagnosis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 146. European Union Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 147. European Union Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
  • TABLE 148. European Union Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
  • TABLE 149. European Union Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
  • TABLE 150. European Union Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 151. European Union Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
  • TABLE 152. European Union Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 153. European Union Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 154. BRICS Neonatal Genetic Disease Diagnosis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 155. BRICS Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 156. BRICS Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
  • TABLE 157. BRICS Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
  • TABLE 158. BRICS Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
  • TABLE 159. BRICS Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 160. BRICS Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
  • TABLE 161. BRICS Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 162. BRICS Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 163. G7 Neonatal Genetic Disease Diagnosis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 164. G7 Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 165. G7 Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
  • TABLE 166. G7 Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
  • TABLE 167. G7 Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
  • TABLE 168. G7 Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 169. G7 Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
  • TABLE 170. G7 Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 171. G7 Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 172. NATO Neonatal Genetic Disease Diagnosis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 173. NATO Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 174. NATO Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
  • TABLE 175. NATO Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
  • TABLE 176. NATO Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
  • TABLE 177. NATO Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 178. NATO Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
  • TABLE 179. NATO Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 180. NATO Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 181. Global Neonatal Genetic Disease Diagnosis Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 182. United States Neonatal Genetic Disease Diagnosis Market Size, 2017-2032 (USD Million)
  • TABLE 183. United States Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 184. United States Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
  • TABLE 185. United States Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
  • TABLE 186. United States Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
  • TABLE 187. United States Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 188. United States Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
  • TABLE 189. United States Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 190. United States Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 191. Canada Neonatal Genetic Disease Diagnosis Market Size, 2017-2032 (USD Million)
  • TABLE 192. Canada Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 193. Canada Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
  • TABLE 194. Canada Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
  • TABLE 195. Canada Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
  • TABLE 196. Canada Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 197. Canada Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
  • TABLE 198. Canada Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 199. Canada Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 200. Mexico Neonatal Genetic Disease Diagnosis Market Size, 2017-2032 (USD Million)
  • TABLE 201. Mexico Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 202. Mexico Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
  • TABLE 203. Mexico Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
  • TABLE 204. Mexico Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
  • TABLE 205. Mexico Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 206. Mexico Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
  • TABLE 207. Mexico Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 208. Mexico Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 209. Brazil Neonatal Genetic Disease Diagnosis Market Size, 2017-2032 (USD Million)
  • TABLE 210. Brazil Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 211. Brazil Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
  • TABLE 212. Brazil Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
  • TABLE 213. Brazil Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
  • TABLE 214. Brazil Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 215. Brazil Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
  • TABLE 216. Brazil Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 217. Brazil Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 218. United Kingdom Neonatal Genetic Disease Diagnosis Market Size, 2017-2032 (USD Million)
  • TABLE 219. United Kingdom Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 220. United Kingdom Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
  • TABLE 221. United Kingdom Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
  • TABLE 222. United Kingdom Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
  • TABLE 223. United Kingdom Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 224. United Kingdom Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
  • TABLE 225. United Kingdom Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 226. United Kingdom Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 227. Germany Neonatal Genetic Disease Diagnosis Market Size, 2017-2032 (USD Million)
  • TABLE 228. Germany Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 229. Germany Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
  • TABLE 230. Germany Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
  • TABLE 231. Germany Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
  • TABLE 232. Germany Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 233. Germany Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
  • TABLE 234. Germany Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 235. Germany Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 236. France Neonatal Genetic Disease Diagnosis Market Size, 2017-2032 (USD Million)
  • TABLE 237. France Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 238. France Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
  • TABLE 239. France Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
  • TABLE 240. France Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
  • TABLE 241. France Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 242. France Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
  • TABLE 243. France Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 244. France Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 245. Russia Neonatal Genetic Disease Diagnosis Market Size, 2017-2032 (USD Million)
  • TABLE 246. Russia Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 247. Russia Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
  • TABLE 248. Russia Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
  • TABLE 249. Russia Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
  • TABLE 250. Russia Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 251. Russia Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
  • TABLE 252. Russia Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 253. Russia Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 254. Italy Neonatal Genetic Disease Diagnosis Market Size, 2017-2032 (USD Million)
  • TABLE 255. Italy Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 256. Italy Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
  • TABLE 257. Italy Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
  • TABLE 258. Italy Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
  • TABLE 259. Italy Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 260. Italy Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
  • TABLE 261. Italy Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 262. Italy Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 263. Spain Neonatal Genetic Disease Diagnosis Market Size, 2017-2032 (USD Million)
  • TABLE 264. Spain Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 265. Spain Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
  • TABLE 266. Spain Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
  • TABLE 267. Spain Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
  • TABLE 268. Spain Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 269. Spain Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
  • TABLE 270. Spain Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 271. Spain Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 272. China Neonatal Genetic Disease Diagnosis Market Size, 2017-2032 (USD Million)
  • TABLE 273. China Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 274. China Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
  • TABLE 275. China Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
  • TABLE 276. China Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
  • TABLE 277. China Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 278. China Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
  • TABLE 279. China Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 280. China Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 281. India Neonatal Genetic Disease Diagnosis Market Size, 2017-2032 (USD Million)
  • TABLE 282. India Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 283. India Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
  • TABLE 284. India Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
  • TABLE 285. India Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
  • TABLE 286. India Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 287. India Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
  • TABLE 288. India Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 289. India Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 290. Japan Neonatal Genetic Disease Diagnosis Market Size, 2017-2032 (USD Million)
  • TABLE 291. Japan Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 292. Japan Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
  • TABLE 293. Japan Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
  • TABLE 294. Japan Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
  • TABLE 295. Japan Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 296. Japan Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
  • TABLE 297. Japan Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 298. Japan Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 299. Australia Neonatal Genetic Disease Diagnosis Market Size, 2017-2032 (USD Million)
  • TABLE 300. Australia Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 301. Australia Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
  • TABLE 302. Australia Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
  • TABLE 303. Australia Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
  • TABLE 304. Australia Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 305. Australia Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
  • TABLE 306. Australia Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 307. Australia Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 308. South Korea Neonatal Genetic Disease Diagnosis Market Size, 2017-2032 (USD Million)
  • TABLE 309. South Korea Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 310. South Korea Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
  • TABLE 311. South Korea Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
  • TABLE 312. South Korea Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
  • TABLE 313. South Korea Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
  • TABLE 314. South Korea Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
  • TABLE 315. South Korea Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 316. South Korea Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 317. Global Neonatal Genetic Disease Diagnosis Market Share, by Key Player, 2025
  • TABLE 318. Global Neonatal Genetic Disease Diagnosis Market, Key Experts